What is FDA clearance for AI medical devices and which pathway is most common?

FDA clearance for AI-enabled medical devices follows the Software as a Medical Device (SaMD) framework. Approximately 95-97% of AI device clearances use the 510(k) pathway, which requires demonstrating substantial equivalence to an existing predicate device rather than the more rigorous De Novo or Premarket Approval (PMA) routes. This matters significantly for procurement decisions: a 510(k)-cleared algorithm has passed a defined regulatory review but the clearance pathway does not guarantee the same depth of clinical validation as a De Novo or PMA pathway product. Radiology dominates FDA clearances, representing 76% of all 1,451 authorised AI devices through end-2025.

What is a predetermined change control plan (PCCP) for AI medical devices?

A Predetermined Change Control Plan (PCCP) is the FDA's framework allowing AI medical device manufacturers to make certain pre-specified updates to an authorised AI model after deployment — without requiring a new submission for each change. This is critical for AI systems that continuously learn or improve, since traditional medical device regulation assumes a static, unchanging product. A PCCP defines the scope of allowed modifications, the methodology for implementing them, and the performance evaluation required to verify the updated model remains safe and effective. Companies building AI that will evolve post-deployment should request PCCP guidance from their development partner as part of the regulatory strategy from the start, not as an afterthought.

Header — TechRadiant Floating Pill

List your agency Share your project →

Top Healthcare AI Development Companies 2026 — TechRadiant

Healthcare Technology 1,451 FDA-cleared AI devices Updated June 2026

Top Healthcare AI Development
Companies 2026 — Verified & Ranked

Q: What is healthcare AI development?

Healthcare AI development is the specialised practice of building artificial intelligence systems for clinical and operational use in healthcare organisations. This includes diagnostic imaging AI (radiology, pathology, dermatology), ambient clinical documentation, clinical decision support systems, predictive risk models, drug discovery AI, and administrative automation agents. What distinguishes healthcare AI development from general AI engineering is the requirement for clinical validation, FDA or EU MDR regulatory pathways for tools that qualify as Software as a Medical Device, bias mitigation across diverse patient populations, and deep integration with clinical workflows and EHR systems.

Q: How big is the healthcare AI market in 2026?

The global AI in healthcare market is projected to reach between $50 billion and $56 billion in 2026, up from approximately $39 billion in 2025 — representing a compound annual growth rate of 38-44% through 2034. This growth reflects a fundamental shift from proof-of-concept pilots to enterprise-scale deployment in clinical documentation, diagnostic imaging, revenue cycle management, and care coordination. The FDA has authorised over 1,451 AI-enabled medical devices for marketing as of end-2025, with 295 new clearances in 2025 alone — up from 253 in 2024 and 221 in 2023, showing clear year-over-year acceleration.

Q: What is the difference between clinical decision support and FDA-regulated AI?

The FDA's Clinical Decision Support (CDS) guidance distinguishes between AI tools that enable independent clinician review — generally not regulated as medical devices — and AI that drives clinical decisions autonomously, which may qualify as Software as a Medical Device (SaMD) requiring FDA clearance. A tool that surfaces information for a clinician to independently evaluate, with the clinician retaining full decision-making authority, typically falls outside device regulation. A tool that makes or directly informs a specific diagnostic or treatment decision without meaningful independent clinician review crosses into SaMD territory. This distinction is critical when scoping a healthcare AI project, as it directly determines development timeline, cost, and regulatory pathway.

Q: How much does healthcare AI development cost?

Healthcare AI development costs vary significantly based on regulatory pathway and clinical complexity. A clinical decision support tool that does not require FDA clearance (clinician retains full independent review) typically costs $80,000-$250,000. An administrative AI agent for revenue cycle, scheduling, or documentation typically costs $100,000-$400,000. A diagnostic imaging AI requiring FDA 510(k) clearance can cost $300,000-$1,000,000+, including regulatory submission costs and clinical validation studies. A novel AI device requiring De Novo or PMA pathway clearance can exceed $2,000,000 when including the multi-year clinical trial and regulatory process. Ongoing model monitoring, retraining, and regulatory maintenance typically add 20-30% of build cost annually.

Q: What are the biggest risks in healthcare AI development?

The primary risks in healthcare AI development are: training data bias, where models trained on non-representative patient populations produce inequitable or unsafe outcomes for underrepresented groups; regulatory misclassification, where a tool is built as clinical decision support but actually functions as an unregulated medical device, exposing the organisation to compliance risk; insufficient clinical validation, where AI is deployed without adequate prospective outcome data proving real-world safety and effectiveness; poor EHR integration, where alerts and outputs do not reach the right clinician at the right moment in their actual workflow; and post-market performance drift, where a model's accuracy degrades over time as patient populations or clinical practices change without adequate monitoring in place.

Q: How does TechRadiant rank healthcare AI development companies?

TechRadiant ranks healthcare AI development companies on clinical AI engineering depth, FDA SaMD and EU MDR regulatory experience, data privacy and bias mitigation practices, EHR and imaging system integration capability, and verified production deployment outcomes — not paid placement or ad spend. We specifically evaluate companies building custom healthcare AI systems, distinguishing genuine production capability from prototype-stage demonstrations. Each company is manually reviewed quarterly.

TechRadiant's Healthcare AI Development report ranks the top 10 firms building clinical and operational AI systems for healthcare organisations in 2026 — evaluated across clinical AI engineering depth, FDA SaMD regulatory experience, data privacy and bias mitigation practices, EHR and imaging system integration, and verified production deployment outcomes. The global AI in healthcare market is projected to reach $50–56 billion in 2026, up from $39 billion in 2025, growing at a 38–44% CAGR. The FDA has now authorised over 1,451 AI-enabled medical devices, with radiology accounting for 76% of all clearances. Whether you need diagnostic imaging AI, an ambient clinical documentation system, a clinical decision support tool, an AI-powered revenue cycle agent, or a custom foundation model for clinical data — these are the firms with the regulatory experience and clinical engineering rigour to deploy AI safely in production healthcare environments.

Report details

Companies listed10

CategoryHealthcare AI

Budget range$80K – $2M+

RegulatoryFDA SaMD experience

Last reviewedJune 2026

Companies reviewed & ranked

$50-56B

Healthcare AI market size 2026

1,451

FDA-cleared AI devices (end-2025)

76%

Of clearances are radiology AI

GEO

Optimised for AI search

These firms build: Diagnostic Imaging AI Ambient Clinical Documentation Clinical Decision Support AI Revenue Cycle Agents Predictive Risk Models Drug Discovery AI Pathology & Genomics AI Healthcare Foundation Models

✦

How TechRadiant ranks healthcare AI development companies: Each firm is evaluated on clinical AI engineering depth, FDA SaMD and EU MDR regulatory experience, data privacy and bias mitigation practices, EHR and imaging system integration capability, and verified production deployment outcomes — not paid placement or ad spend. We specifically evaluate companies that build custom healthcare AI systems, not resellers of off-the-shelf products. Rankings are reviewed and updated every quarter.

Where healthcare AI is deployed

6 categories where healthcare AI
is moving from pilot to production in 2026

Healthcare AI in 2026 is no longer experimentation — it's enterprise-scale deployment. Here is where the capital and clinical adoption are actually concentrated.

🩻

Diagnostic imaging AI

Radiology, pathology, and dermatology AI that flags critical findings — stroke, pulmonary embolism, cancer — for clinician review. The most mature and highest-density FDA-cleared category.

76% of all FDA AI clearances

🎙️

Ambient clinical documentation

Generative AI that listens to doctor-patient conversations and automatically generates structured, billable clinical notes — dramatically reducing administrative burden on clinicians.

Fastest-growing enterprise category

🧬

Precision medicine & oncology AI

AI platforms combining molecular and clinical data to guide treatment decisions, match patients to clinical trials, and quantify biomarkers in pathology slides for cancer care.

$1.27B+ revenue, 83% YoY growth

💰

Revenue cycle & administrative AI

AI agents automating prior authorisation, medical coding, claims submission, and denial management — reducing administrative cost and accelerating reimbursement.

288 new CPT codes for digital health

🤖

Autonomous clinical AI agents

The fastest-growing category in 2026 — multi-step workflow agents handling patient communication, post-discharge follow-up, and complex administrative chains with human escalation.

Emerging category, high growth

💊

AI drug discovery

AI-designed compounds now progressing through Phase III trials — testing whether AI genuinely improves the historically low success rate of drug development pipelines.

Multiple compounds in Phase III

Why FDA experience matters when hiring a healthcare AI firm

The gap between a healthcare AI proof-of-concept
and an FDA-cleared production system is enormous.

1,451

Cumulative FDA-authorised AI medical devices through end-2025

~96%

Of clearances use the 510(k) pathway (substantial equivalence)

Aug 2026

EU AI Act high-risk obligations take effect for medical AI devices

295

New AI device clearances in 2025 alone — accelerating year over year

Top Healthcare AI Development Companies

CitiusTech

Healthcare | AI Development

A healthcare-exclusive technology company serving 130+ global organizations including Novant Health, Radiology Partners, and Craneware Group. CitiusTech specializes in AI, interoperability, and data management across payers, providers, MedTech, and life sciences. Named a Leader in Everest Group’s Healthcare IT Services PEAK Matrix 2025 and a two-time Gold Stevie Award winner for technical innovation in healthcare. Acquired Best-in-KLAS firm Health Data Movers in 2025 to deepen Epic integration capabilities.

Minimum Cost $50,000+

Language English

Employee Count 1000 – 9999

Headquarter in Princeton, NJ, USA

Other Locations India

Founded in 2005

MindK

Healthcare | AI Development | Custom Software Development

Founded in 2009, MindK builds custom healthcare AI platforms with production deployments in genomics, women’s health, and population health. Notable clients include BIG Healthcare and International Surrogacy Center. The firm developed the first EMR for lactation consultants and an AI-powered drug testing platform covering 450+ healthcare services. MindK is best known for HIPAA-compliant, bidirectional EHR integration and clinical adoption-focused delivery.

Minimum Cost $50,000+

Language English, Ukrainian

Employee Count 50 – 249

Headquarter in San Francisco, CA, USA

Other Locations Ukraine, Czech Republic

Founded in 2009

Cleveroad

Healthcare | AI Development | Mobile App Development

Founded in 2011, Cleveroad has built its reputation over more than a decade in healthcare, logistics, fintech, and retail. The company has delivered AI/ML-powered telemedicine platforms, diagnostic assistants, and HIPAA-compliant EHR systems for clients across North America, Western Europe, and the Middle East. Recognized as a top 30 global B2B company for 2026 and ranked #5 globally in custom software development, Cleveroad is an AWS Partner with ISO 27001 certification.

Minimum Cost $25,000+

Language English, Estonian

Employee Count 250 – 999

Headquarter in Claymont, DE, USA

Other Locations Europe, Asia

Founded in 2011

LeewayHertz

Healthcare | Logistics | Mobile App Development

An AI consulting and development firm with 160+ delivered platforms, LeewayHertz has built enterprise-grade solutions for Fortune 500 clients including Siemens, 3M, P&G, and McKinsey. In healthcare, the company develops generative AI-powered clinical documentation tools, AI medical assistants, and EHR enhancement platforms. Named a representative vendor in Gartner’s 2024 Hype Cycle for Generative AI and recognized as a top AI consulting firm by Forbes. Acquired by The Hackett Group in 2024.

Minimum Cost $25,000+

Language English

Employee Count 50 – 249

Headquarter in Gurgaon, India

Other Locations San Francisco

Founded in 2007

Softeq

Healthcare | Custom Software Development | Mobile App Development

Softeq provides early-stage innovation, technology business consulting, and full-stack development solutions to enterprise companies and innovative startups. In healthcare, Softeq is the go-to partner for medical imaging AI and connected device development with deep DICOM pipeline, PACS integration, and FDA SaMD pathway experience. Clients include Microsoft, NVIDIA, and Epson. ISO 13485-certified and named to the Inc. 5000 list five times.

Minimum Cost $50,000+

Language English, Polish, Spanish

Employee Count 50 – 249

Headquarter in Houston, TX, USA

Other Locations Poland, Lithuania, Mexico

Founded in 1997

Mid-List CTA — TechRadiant

Free matching service

Not sure which
Healthcare AI Development Company fits your project?

Tell us your requirements once. We'll send you a curated shortlist of verified healthcare AI development companies — matched to your industry, budget, and timeline.

Share your project →

What you get

✓ A shortlist of 3–5 verified healthcare AI development companies matched to your specific project needs

✓ Filtered by budget, location, and industry — no irrelevant suggestions

✓ Response within 48 hours — no calls, no forms, no back-and-forth

✓ 100% free for businesses — you connect directly with the firms you choose

✦

Human-curated, not algorithm-generated. Every shortlist is reviewed by our research team before it reaches you.

Health Catalyst

Healthcare | Custom Software Development | Mobile App Development

A publicly traded (NASDAQ: HCAT) healthcare data platform company powering clinical and operational AI across 40+ major U.S. health systems. Documented clients include Allina Health, Texas Children’s Hospital, MultiCare Health System, and WakeMed — with verified outcomes including $74M in performance improvements at Texas Children’s and a 22% reduction in sepsis mortality at MultiCare. Their Late-Binding Data Warehouse is deployed across tens of millions of patient records, giving health systems a pre-built AI foundation.

Minimum Cost $100,000+

Language English

Employee Count 1000 – 9999

Headquarter in Salt Lake City, UT, USA

Other Locations –

Founded in 2008

Tempus AI

Healthcare

Tempus AI, Inc. is a technology company leading the adoption of AI to advance precision medicine and patient care. The company has processed over 40 million clinical records and sequenced approximately 4 million samples. In 2025, Tempus announced a multi-year strategic collaboration with AstraZeneca and Pathos to build the largest multimodal foundation model in oncology, with $200M in commitments over three years. Revenue grew 89.6% year-over-year in Q2 2025, with full-year 2025 guidance of $1.25 billion.

Minimum Cost –

Language English

Employee Count 1000 – 9999

Headquarter in Chicago, IL, USA

Other Locations New York, San Francisco

Founded in 2015

Hippocratic AI

Healthcare | AI Agent

Hippocratic AI has established partnerships with over 50 large health systems, payors, and pharma clients in 6 countries, including Cleveland Clinic, Northwestern Medicine, Ochsner Health, and Universal Health Services. Its safety-focused generative AI agents have completed 180M+ clinical patient interactions across 1,000+ use cases with no safety incidents. Backed by $404M from Andreessen Horowitz, General Catalyst, Kleiner Perkins, and Google’s CapitalG, with a $3.5B valuation as of November 2025.

Minimum Cost –

Language English

Employee Count 250 – 999

Headquarter in Palo Alto, CA, USA

Other Locations –

Founded in 2023

Aidoc

Healthcare | Custom Software Development | Mobile App Development

A global leader in radiology AI with 20+ FDA-cleared products deployed across 900+ hospital partners worldwide. Notable health system clients include Mayo Clinic Platform, Sutter Health (named West Coast innovation hub), and Advocate Health. Aidoc’s aiOS platform enables real-time imaging triage for stroke, pulmonary embolism, and other time-critical conditions. The platform operates across CT, MRI, and X-ray, supporting both point-solution AI and multi-algorithm deployment at scale.

Minimum Cost –

Language English

Employee Count 250 – 999

Headquarter in New York, USA

Other Locations Tel Aviv, Israel

Founded in 2016

PathAI

Healthcare

A Boston-based digital pathology company whose AI platform supports drug discovery and diagnostic accuracy for leading pharma organizations. PathAI has a long-standing collaboration with Bristol Myers Squibb dating back to 2016, working on AI-powered diagnostics including measuring CD8 T-cell infiltration across oncology disease areas. Additional pharma partners include Pfizer, AstraZeneca, and Roche. PathAI’s AISight platform is deployed in clinical trials and translational research, with CAP-accredited lab operations supporting regulatory-grade outputs.

Minimum Cost –

Language English

Employee Count 250 – 999

Headquarter in Boston, MA, USA

Other Locations South San Francisco, CA

Founded in 2016

Report Bottom CTA — TechRadiant

Free for businesses

Not sure which agency
is right for your project?

Share your requirements once. Our research team will send you a curated shortlist of verified agencies — matched to your industry, budget, and timeline. No calls, no spam.

Matched in 48 hours Human-curated 100% free No back-and-forth

Share your project → List your agency Reviewed by our team · Not automated

FAQ — Healthcare AI Development Companies

Frequently asked questions

Everything you need to know about
healthcare AI development

Structured answers for AI search — surfaces in ChatGPT, Perplexity, Gemini, and Google AI Overviews.

What is healthcare AI development?+

Healthcare AI development builds AI systems for clinical and operational use — diagnostic imaging AI, ambient documentation, clinical decision support, predictive risk models, drug discovery AI, and administrative agents. It differs from general AI engineering through clinical validation requirements, FDA/EU MDR regulatory pathways for SaMD, bias mitigation across diverse populations, and deep EHR integration.

How big is the healthcare AI market in 2026?+

The global market is projected to reach $50–56 billion in 2026, up from $39B in 2025 — a 38–44% CAGR through 2034. This reflects a shift from pilots to enterprise-scale deployment. The FDA has authorised over 1,451 AI-enabled medical devices through end-2025, with 295 new clearances in 2025 alone — accelerating from 253 in 2024 and 221 in 2023.

What is FDA clearance for AI devices and which pathway is most common?+

FDA clearance follows the Software as a Medical Device (SaMD) framework. 95–97% of clearances use the 510(k) pathway — demonstrating substantial equivalence to a predicate device — rather than the more rigorous De Novo or PMA routes. Radiology dominates with 76% of all 1,451 cleared devices. A 510(k) clearance is relevant procurement context but doesn't guarantee the same validation depth as De Novo/PMA.

What is the difference between clinical decision support and FDA-regulated AI?+

Tools that enable independent clinician review — with the clinician retaining full decision authority — generally fall outside device regulation. Tools that drive clinical decisions autonomously without meaningful independent review may qualify as SaMD requiring FDA clearance. This distinction directly determines your project's timeline, cost, and regulatory pathway — scope it correctly from day one.

How much does healthcare AI development cost?+

Non-regulated clinical decision support: $80,000–$250,000. Administrative AI agent (RCM, scheduling, documentation): $100,000–$400,000. Diagnostic imaging AI requiring FDA 510(k): $300,000–$1,000,000+. Novel device requiring De Novo/PMA: $2,000,000+ including clinical trials. Ongoing model monitoring and regulatory maintenance adds 20–30% annually.

What is a predetermined change control plan (PCCP)?+

A PCCP is the FDA's framework allowing pre-specified updates to an authorised AI model post-deployment — without a new submission for each change. Critical for continuously learning AI systems since traditional device regulation assumes a static product. It defines the scope of allowed modifications and required performance evaluation. Request PCCP guidance from your dev partner from the start — not as an afterthought.

What are the biggest risks in healthcare AI development?+

Key risks: training data bias producing inequitable outcomes for underrepresented groups, regulatory misclassification (CDS tool that's actually unregulated SaMD), insufficient clinical validation, poor EHR integration where alerts miss the right clinician, and post-market performance drift as populations and practices change without adequate monitoring.

How does TechRadiant rank healthcare AI development companies?+

TechRadiant ranks on clinical AI engineering depth, FDA SaMD and EU MDR regulatory experience, data privacy and bias mitigation, EHR and imaging integration, and verified production deployment outcomes — not paid placement. We evaluate companies building custom healthcare AI, distinguishing real production capability from prototypes. Share your project and we'll match you to the right firm.

Not sure which healthcare AI development firm fits your project? Share your requirements — we'll send a verified shortlist within 48 hours. Free.

Get matched now →

Featured Reports — TechRadiant

Research-led reports